Ramelteon attenuates hippocampal neuronal loss and memory impairment following kainate‐induced seizures
Journal of Pineal Research · 2024
DOI: 10.1111/jpi.12921 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pineal Research, 2024. Verfasst von Jung Hoon Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Chuncheon, Republic of Korea. Hauptthemen laut MEDLINE: Melatonin, Indenes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korea Basic Science Institute.
Abstract (Originalsprache)
Evidence suggests that the neuroprotective effects of melatonin involve both receptor‐dependent and ‐independent actions. However, little is known about the effects of melatonin receptor activation on the kainate (KA) neurotoxicity. This study examined the effects of repeated post‐KA treatment with ramelteon, a selective agonist of melatonin receptors, on neuronal loss, cognitive impairment, and depression‐like behaviors following KA‐induced seizures. The expression of melatonin receptors decreased in neurons, whereas it was induced in astrocytes 3 and 7 days after seizures elicited by KA (0.12 μg/μL) in the hippocampus of mice. Ramelteon (3 or 10 mg/kg, i.p.) and melatonin (10 mg/kg, i.p.) mitigated KA‐induced oxidative stress and impairment of glutathione homeostasis and promoted the nuclear translocation and DNA binding activity of Nrf2 in the hippocampus after KA treatment. Ramelteon and melatonin also attenuated microglial activation but did not significantly affect astroglial activation induced by KA, despite the astroglial induction of melatonin receptors after KA treatment. However, ramelteon attenuated KA‐induced proinflammatory phenotypic changes in astrocytes. Considering the reciprocal regulation of astroglial and microglial activation, these results suggest ramelteon inhibits microglial activation by regulating astrocyte phenotypic changes. These effects were accompanied by the attenuation of the nuclear translocation and DNA binding activity of nuclear factor κB (NFκB) induced by KA. Consequently, ramelteon attenuated the KA‐induced hippocampal neuronal loss, memory impairment, and depression‐like behaviors; the effects were comparable to those of melatonin. These results suggest that ramelteon‐mediated activation of melatonin receptors provides neuroprotection against KA‐induced neurotoxicity in the mouse hippocampus by activating Nrf2 signaling to attenuate oxidative stress and restore glutathione homeostasis and by inhibiting NFκB signaling to attenuate neuroinflammatory changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Chuncheon, Republic of Korea.
Förderung
- National Research Foundation of Korea
- Korea Basic Science Institute
Zitieren
APA
Park, J. H., Hwang, Y., Nguyen, Y. N. D., Kim, H. C., & Shin, E. J. (2024). Ramelteon attenuates hippocampal neuronal loss and memory impairment following kainate‐induced seizures. Journal of Pineal Research. https://doi.org/10.1111/jpi.12921
Vancouver
Park JH, Hwang Y, Nguyen YND, Kim HC, Shin EJ. Ramelteon attenuates hippocampal neuronal loss and memory impairment following kainate‐induced seizures. Journal of Pineal Research. 2024. doi:10.1111/jpi.12921
BibTeX
@article{Park2024,
author = {Park, Jung Hoon and Hwang, Yeonggwang and Nguyen, Yen Nhi Doan and Kim, Hyoung-Chun and Shin, Eun-Joo},
title = {Ramelteon attenuates hippocampal neuronal loss and memory impairment following kainate‐induced seizures},
journal = {Journal of Pineal Research},
year = {2024},
doi = {10.1111/jpi.12921}
}
EUVIMED